← Back to Clinical Trials
Recruiting NCT07285330

NCT07285330 Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07285330
Status Recruiting
Phase
Sponsor Consorci Sanitari de l'Alt Penedès i Garraf
Condition Diabetes (DM)
Study Type OBSERVATIONAL
Enrollment 140 participants
Start Date 2025-06-30
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Day Care HospitalNutritionist

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 140 participants in total. It began in 2025-06-30 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.

Eligibility Criteria

Inclusion Criteria: * Patients with a diagnosis of type 2 diabetes (T2DM) referred to endocrinology due to poor metabolic control. * Patients on insulin therapy Exclusion Criteria: * Referred from primary care for other reasons such as hypoglycemia. * Patients with other types of diabetes mellitus or with uncertainty in diagnostic classification. * Patients on rapid-acting insulin bolus therapy. * Patients with acute decompensation of diabetes. * Patients receiving corticosteroid treatment. * Dependent individuals for activities of daily living (ADL) with a Barthel index score below 60 or with cognitive impairment. * Language barrier.

Contact & Investigator

Central Contact

Noemí Casaponsa

✉ recerca@csapg.cat

📞 +34 938960025

Frequently Asked Questions

Who can join the NCT07285330 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes (DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07285330 currently recruiting?

Yes, NCT07285330 is actively recruiting participants. Contact the research team at recerca@csapg.cat for enrollment information.

Where is the NCT07285330 trial being conducted?

This trial is being conducted at Vilafranca del Penedès, Spain.

Who is sponsoring the NCT07285330 clinical trial?

NCT07285330 is sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. The trial plans to enroll 140 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology